iBio, Inc.IBIONYSE
Loading
Cash Flow PerformanceElevated
Percentile Rank21
Studio
Year-over-Year Change

Free cash flow yield

Latest
-191.22%
↑ 41% vs avg
Percentile
P21
Within normal range
Streak
3 yr
Consecutive growthElevated
Average
-325.35%
Historical baseline
PeriodValueYoY Change
2025-191.22%+21.5%
2024-243.68%+49.7%
2023-484.29%+75.7%
2022-1990.42%-16590.6%
2021-11.93%-14.7%
2020-10.40%+90.8%
2019-112.96%+25.8%
2018-152.17%-258.4%
2017-42.46%-204.1%
2016-13.96%-